Related Experiment Videos
Periprocedural management of the chronically anticoagulated patient: critical pathways for bridging therapy
Gregory Piazza1, Samuel Z Goldhaber
1Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Insights
Bridging anticoagulation therapy is crucial for patients with nonvalvular atrial fibrillation and other high-risk conditions. Low-molecular-weight heparin (LMWH) is now a safe and effective alternative to unfractionated heparin for periprocedural bridging.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Patients on long-term anticoagulation require careful management during procedures.
- Indications for periprocedural bridging include nonvalvular atrial fibrillation, prosthetic heart valves, recent venous thromboembolism, and hypercoagulable states.
Purpose of the Study:
- To evaluate low-molecular-weight heparin (LMWH) as a safe and effective alternative for periprocedural bridging in patients requiring oral anticoagulation.
Main Methods:
- Review of current clinical practices and emerging evidence regarding anticoagulation bridging strategies.
- Comparison of unfractionated heparin (UFH) with LMWH for periprocedural bridging.
Main Results:
- Low-molecular-weight heparin (LMWH) has emerged as a safe and effective alternative to intravenous unfractionated heparin for bridging therapy.
- LMWH offers potential advantages in periprocedural anticoagulation management.
Conclusions:
- Low-molecular-weight heparin (LMWH) is a viable and recommended option for periprocedural bridging in specific patient populations.
- The use of LMWH represents an advancement in managing anticoagulation for procedures.
Abstract:
Periprocedural bridging of the patient on long-term anticoagulation is indicated in nonvalvular atrial fibrillation with additional risk factors, prosthetic heart valves, venous thromboembolism within 3 months of the procedure, and hypercoagulable conditions requiring oral anticoagulation. Until recently, intravenous unfractionated heparin was used for bridging. LMWH has now emerged as a safe and effective bridging alternative.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care